Literature DB >> 26106140

Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?

R Brooks Robey1, Judith Weisz2, Nancy B Kuemmerle3, Anna C Salzberg2, Arthur Berg2, Dustin G Brown4, Laura Kubik5, Roberta Palorini6, Fahd Al-Mulla7, Rabeah Al-Temaimi7, Annamaria Colacci8, Chiara Mondello9, Jayadev Raju10, Jordan Woodrick11, A Ivana Scovassi9, Neetu Singh12, Monica Vaccari8, Rabindra Roy11, Stefano Forte13, Lorenzo Memeo13, Hosni K Salem14, Amedeo Amedei15, Roslida A Hamid16, Graeme P Williams17, Leroy Lowe18, Joel Meyer5, Francis L Martin19, William H Bisson20, Ferdinando Chiaradonna6, Elizabeth P Ryan4.   

Abstract

Environmental contributions to cancer development are widely accepted, but only a fraction of all pertinent exposures have probably been identified. Traditional toxicological approaches to the problem have largely focused on the effects of individual agents at singular endpoints. As such, they have incompletely addressed both the pro-carcinogenic contributions of environmentally relevant low-dose chemical mixtures and the fact that exposures can influence multiple cancer-associated endpoints over varying timescales. Of these endpoints, dysregulated metabolism is one of the most common and recognizable features of cancer, but its specific roles in exposure-associated cancer development remain poorly understood. Most studies have focused on discrete aspects of cancer metabolism and have incompletely considered both its dynamic integrated nature and the complex controlling influences of substrate availability, external trophic signals and environmental conditions. Emerging high throughput approaches to environmental risk assessment also do not directly address the metabolic causes or consequences of changes in gene expression. As such, there is a compelling need to establish common or complementary frameworks for further exploration that experimentally and conceptually consider the gestalt of cancer metabolism and its causal relationships to both carcinogenesis and the development of other cancer hallmarks. A literature review to identify environmentally relevant exposures unambiguously linked to both cancer development and dysregulated metabolism suggests major gaps in our understanding of exposure-associated carcinogenesis and metabolic reprogramming. Although limited evidence exists to support primary causal roles for metabolism in carcinogenesis, the universality of altered cancer metabolism underscores its fundamental biological importance, and multiple pleiomorphic, even dichotomous, roles for metabolism in promoting, antagonizing or otherwise enabling the development and selection of cancer are suggested. Published by Oxford University Press 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26106140      PMCID: PMC4565609          DOI: 10.1093/carcin/bgv037

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  281 in total

1.  THE RELATIONSHIPS BETWEEN SUBSTRATES AND ENZYMES OF GLYCOLYSIS IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Cancer: drivers and passengers.

Authors:  Daniel A Haber; Jeff Settleman
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

3.  Control of glucose phosphorylation in L6 myotubes by compartmentalization, hexokinase, and glucose transport.

Authors:  Richard R Whitesell; Hossein Ardehali; Richard L Printz; Joseph M Beechem; Susan M Knobel; David W Piston; Daryl K Granner; Wieb Van Der Meer; Laureta M Perriott; James M May
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

4.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

5.  Evidence for an alternative glycolytic pathway in rapidly proliferating cells.

Authors:  Matthew G Vander Heiden; Jason W Locasale; Kenneth D Swanson; Hadar Sharfi; Greg J Heffron; Daniel Amador-Noguez; Heather R Christofk; Gerhard Wagner; Joshua D Rabinowitz; John M Asara; Lewis C Cantley
Journal:  Science       Date:  2010-09-17       Impact factor: 47.728

Review 6.  Asparagine synthetase: regulation by cell stress and involvement in tumor biology.

Authors:  Mukundh N Balasubramanian; Elizabeth A Butterworth; Michael S Kilberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-12       Impact factor: 4.310

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 8.  Arginine metabolism: boundaries of our knowledge.

Authors:  Sidney M Morris
Journal:  J Nutr       Date:  2007-06       Impact factor: 4.798

9.  Resistance to fluid shear stress is a conserved biophysical property of malignant cells.

Authors:  J Matthew Barnes; Jones T Nauseef; Michael D Henry
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

Review 10.  Sugar and fat - that's where it's at: metabolic changes in tumors.

Authors:  Christian D Young; Steven M Anderson
Journal:  Breast Cancer Res       Date:  2008-02-20       Impact factor: 6.466

View more
  34 in total

Review 1.  Lipid Metabolism in Tumor-Associated Fibroblasts.

Authors:  Hongzhong Li; Jingyuan Wan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  In Vivo Determination of Mitochondrial Function Using Luciferase-Expressing Caenorhabditis elegans: Contribution of Oxidative Phosphorylation, Glycolysis, and Fatty Acid Oxidation to Toxicant-Induced Dysfunction.

Authors:  Anthony L Luz; Cristina Lagido; Matthew D Hirschey; Joel N Meyer
Journal:  Curr Protoc Toxicol       Date:  2016-08-01

Review 3.  Architecture in 3D cell culture: An essential feature for in vitro toxicology.

Authors:  Sophie A Lelièvre; Tim Kwok; Shirisha Chittiboyina
Journal:  Toxicol In Vitro       Date:  2017-03-30       Impact factor: 3.500

Review 4.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

Review 5.  Metabolic flux between organs measured by arteriovenous metabolite gradients.

Authors:  Hosung Bae; Katie Lam; Cholsoon Jang
Journal:  Exp Mol Med       Date:  2022-09-08       Impact factor: 12.153

Review 6.  Lipid metabolism in tumor microenvironment: novel therapeutic targets.

Authors:  Xingkai Liu; Ping Zhang; Jing Xu; Guoyue Lv; Yan Li
Journal:  Cancer Cell Int       Date:  2022-07-05       Impact factor: 6.429

7.  From the Cover: Arsenite Uncouples Mitochondrial Respiration and Induces a Warburg-like Effect in Caenorhabditis elegans.

Authors:  Anthony L Luz; Tewodros R Godebo; Dhaval P Bhatt; Olga R Ilkayeva; Laura L Maurer; Matthew D Hirschey; Joel N Meyer
Journal:  Toxicol Sci       Date:  2016-05-20       Impact factor: 4.849

8.  Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity.

Authors:  Rob J W Arts; Boris Novakovic; Rob Ter Horst; Agostinho Carvalho; Siroon Bekkering; Ekta Lachmandas; Fernando Rodrigues; Ricardo Silvestre; Shih-Chin Cheng; Shuang-Yin Wang; Ehsan Habibi; Luís G Gonçalves; Inês Mesquita; Cristina Cunha; Arjan van Laarhoven; Frank L van de Veerdonk; David L Williams; Jos W M van der Meer; Colin Logie; Luke A O'Neill; Charles A Dinarello; Niels P Riksen; Reinout van Crevel; Clary Clish; Richard A Notebaart; Leo A B Joosten; Hendrik G Stunnenberg; Ramnik J Xavier; Mihai G Netea
Journal:  Cell Metab       Date:  2016-11-17       Impact factor: 27.287

Review 9.  Energy metabolic dysfunction as a carcinogenic factor in cancer cells.

Authors:  Yongyan Sun; Zhenhua Shi; Huiyong Lian; Peng Cai
Journal:  Clin Transl Med       Date:  2016-04-06

10.  Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM.

Authors:  Hongming Miao; Juanjuan Ou; Yuan Peng; Xuan Zhang; Yujuan Chen; Lijun Hao; Ganfeng Xie; Zhe Wang; Xueli Pang; Zhihua Ruan; Jianjun Li; Liqing Yu; Bingzhong Xue; Hang Shi; Chunmeng Shi; Houjie Liang
Journal:  Nat Commun       Date:  2016-05-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.